Anti-CYP2C9 / Cytochrome P450 2C9, clone CYP2C9/13121

Anti-CYP2C9 / Cytochrome P450 2C9, clone CYP2C9/13121
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NSJ-V5682-20UG 20 µg - -

3 - 10 business days*

361.00€
NSJ-V5682-100UG 100 µg - -

3 - 10 business days*

781.00€
 
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide. This gene encodes a... more
Product information "Anti-CYP2C9 / Cytochrome P450 2C9, clone CYP2C9/13121"
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide. This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Protein function: A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and steroids (PubMed:12865317, PubMed:15766564, PubMed:19965576, PubMed:21576599, PubMed:7574697, PubMed:9435160, PubMed:9866708). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:12865317, PubMed:15766564, PubMed:19965576, PubMed:21576599, PubMed:7574697, PubMed:9435160, PubMed:9866708). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFA) (PubMed:15766564, PubMed:19965576, PubMed:7574697, PubMed:9866708). Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis (PubMed:21576599). Exhibits low catalytic activity for the formation of catechol estrogens from 17beta- estradiol (E2) and estrone (E1), namely 2-hydroxy E1 and E2 (PubMed:12865317). Catalyzes bisallylic hydroxylation and hydroxylation with double-bond migration of polyunsaturated fatty acids (PUFA) (PubMed:9435160, PubMed:9866708). Also metabolizes plant monoterpenes such as limonene. Oxygenates (R)- and (S)-limonene to produce carveol and perillyl alcohol (PubMed:11950794). Contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S- warfarin, diclofenac, phenytoin, tolbutamide and losartan (PubMed:25994031). [The UniProt Consortium]
Keywords: Anti-CYPIIC9, Anti-Cytochrome P-450MP, Anti-Cytochrome P450 2C9, Anti-Cytochrome P450 MP-8, Anti-Cytochrome P450 MP-4, Anti-Cytochrome P450 PB-1, Anti-Cholesterol 25-hydroxylase, Anti-S-mephenytoin 4-hydroxylase, Anti-(S)-limonene 6-monooxygenase, CYP2C9
Supplier: NSJ Bioreagents
Supplier-Nr: V5682

Properties

Application: IHC (paraffin)
Antibody Type: Monoclonal
Clone: CYP2C9/13121
Conjugate: No
Host: Mouse
Species reactivity: human
Immunogen: A portion of amino acids 1-200 from the human protein
Format: Purified

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-CYP2C9 / Cytochrome P450 2C9, clone CYP2C9/13121"
Write a review
or to review a product.
Viewed